Bure Equity is a situation-based investment company. It was founded in 1992 with the abolition of Sweden’s wage-earner funds. Over its 25-year history, Bure Equity has built a diversified portfolio, comprised of nine companies. The listed companies are the Cavotec engineering group, the MedCap investor in the Life Science sector, the Mycronic electronics designer, the Vitrolife medtech group, and the Xvivo Perfusion medtech company, specialising in transplantation. The Bure Equity unlisted holdings include Bure Financial Services, Bure Growth, Investment AB Bure, and Mercuri International. The Bure Equity group has traded on the NASDAQ Stockholm since 1993. The company’s share price is listed under the BURE ticker in the Mid Cap list. Follow the latest Bure Equity share price trends at Capital.com. Markets swing as traders re-adjust to trading in Trump’s worldExplore market reactions to Trump's trade policies, including USD drops, oil price shifts, and tariff impacts.
08:15, 21 January 2025
USD/JPY drops below 156 as US CPI eases and BOJ rate hike expectations increaseAn increase in rate hike expectations from the BOJ and softer US CPI data see USD/JPY turn lower
14:47, 16 January 2025
UK inflation cools in December, GBP/USD attempts to bounce backUK inflation drops more than expected in December, easing some of the fears about the UK economy.
09:41, 15 January 2025
Market Analysis: EUR/GBP Extends Rally but Faces Key ResistanceA worsening economic outlook in the UK is driving the pound lower, pushing EUR/GBP to a two-and-a-half-month high.
14:56, 14 January 2025